Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 26, 1527-1533, July 1, 1966]
© 1966 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Isojima, S.
Right arrow Articles by Pressman, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Isojima, S.
Right arrow Articles by Pressman, D.

Differences between the Microsomes of Normal Rat Liver and of N-2-Fluorenylacetamide-induced Rat Hepatoma as Determined by the Paired Label Antibody Technic1

Shinzo Isojima2, Jakob Planinsek, Yasuo Yagi and David Pressman

Department of Biochemistry Research, Roswell Park Memorial Institute,3 Buffalo, New York

Rabbit antibodies against the microsome fractions of a chemically induced rat hepatoma and of normal rat liver were compared by the paired label radioantibody technic. The antihepatoma antibodies were labeled with 125I and the anti-normal-liver antibodies were labeled with 131I. The 2 were mixed and then injected or treated in vitro simultaneously. The 2 antibodies differed in vivo in their localizing properties in hepatoma and in normal liver. They were fractionated in vitro into fractions containing hepatomaphilic or normal-liver-philic antibodies. The results indicate differences in the antigen composition between the microsome fractions of the 2 tissues as well as differences in the antibody composition between the antisera produced against these preparations.

1 Supported in part by Contract AT-2651 from the U.S. Atomic Energy Commission and Grant T-242 from the American Cancer Society.

2 This work was done during a leave of absence from the Department of Obstetrics and Gynecology, Osaka University Medical School, Osaka, Japan (present address).

3 A unit of the New York State Department of Health.

Received 8/19/65. Revised 1/20/66.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1966 by the American Association for Cancer Research.